Literature DB >> 18668025

Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.

M Odette Gore1, Brian J Welch, Weidong Geng, Wareef Kabbani, Naim M Maalouf, Joseph E Zerwekh, Orson W Moe, Khashayar Sakhaee.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18668025      PMCID： PMC2878273          DOI： 10.1038/ki.2008.355

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  22 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  M K Drezner
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Octreotide therapy for tumor-induced osteomalacia.

Authors:  J Seufert; K Ebert; J Müller; J Eulert; C Hendrich; E Werner; N Schuüze; G Schulz; W Kenn; H Richtmann; K D Palitzsch; F Jakob
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

3.  Octreotide for tumor-induced osteomalacia.

Authors:  Federica Paglia; Simona Dionisi; Salvatore Minisola
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

Review 4.  Phosphatonins: a new class of phosphate-regulating proteins.

Authors:  Susan C Schiavi; Orson W Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-07       Impact factor: 2.894

5.  Localisation of mesenchymal tumours by somatostatin receptor imaging.

Authors:  Suzanne M Jan de Beur; Elizabeth A Streeten; A Cahid Civelek; Edward F McCarthy; Liliana Uribe; Stephen J Marx; Olufunmilayo Onobrakpeya; Lawrence G Raisz; Nelson B Watts; Michael Sharon; Michael A Levine
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

6.  Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.

Authors:  Q L Huang; D S Feig; M E Blackstein
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

Review 7.  Tumor-induced osteomalacia and the regulation of phosphate homeostasis.

Authors:  R Kumar
Journal:  Bone       Date:  2000-09       Impact factor: 4.398

8.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

9.  Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin.

Authors:  Michel Baum; Samer Loleh; Neel Saini; Mouin Seikaly; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

Review 10.  FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.

Authors:  L Darryl Quarles
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07       Impact factor: 4.310
View more
  8 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.

Authors:  Uri S Alon
Journal:  Eur J Pediatr       Date:  2010-12-31       Impact factor: 3.183

Review 3.  Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.

Authors:  Jyothsna Gattineni; Michel Baum
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

4.  Osteomalacia caused by tumors in facies cranii mimicking rheumatoid arthritis.

Authors:  Wang Xian-Ling; Ba Jian-Ming; Zhong Wen-Wen; Lü Zhao-Hui; Dou Jing-Tao; Lu Ju-Ming; Mu Yi-Ming
Journal:  Rheumatol Int       Date:  2011-07-26       Impact factor: 2.631

Review 5.  Hypophosphatemic rickets due to perturbations in renal tubular function.

Authors:  Maria Goretti M G Penido; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2013-05-01       Impact factor: 3.714

6.  Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level.

Authors:  Ambika Amblee; Juanito Uy; Carmencita Senseng; Peter Hart
Journal:  Clin Kidney J       Date:  2014-02-25

7.  Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.

Authors:  Qing-Yao Zuo; Hong Wang; Wei Li; Xiao-Hui Niu; Yan-Hong Huang; Jia Chen; Yu-Hua You; Bao-Yue Liu; Ai-Min Cui; Wei Deng
Journal:  BMC Musculoskelet Disord       Date:  2017-09-21       Impact factor: 2.362

8.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.